Xolair® (omalizumab) enrollment in a tertiary care allergy and asthma clinic in Canada
Crossref DOI link: https://doi.org/10.1186/1710-1492-10-S2-A5
Published Online: 2014-12-18
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Cameron, Jodi
Forgie, Jennifer
Ring, Alicia
Santucci, Stephanie
Rizk, Caroline
Pham, Hoang
O’Quinn, John
Yang, William H
Article History
First Online: 18 December 2014